Kuhli-Hattenbach C, Scharrer I, Lüchtenberg M, Hattenbach L-O
Klinik für Augenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Klin Monbl Augenheilkd. 2008 Dec;225(12):1065-9. doi: 10.1055/s-2008-1027488. Epub 2008 Dec 15.
The potential impact of coagulation abnormalities on non-arteritic ischaemic optic neuropathy (NAION), individually and in combination with cardiovascular risk factors, remains unclear.
In a prospective case-control study a cohort of 26 NAION patients < 60 years at the time of the NAION or a previous thromboembolic event and 50 subjects matched for age and sex were prospectively screened for thrombophilic risk factors.
Overall, thrombophilic defects were found to be present in 12 of 26 patients (46.2 %) and in 9 of 50 (18 %) controls (p = 0.01). The most frequent coagulation disorders were high levels of factor VIII (p = 0.04) and lipoprotein (a) (p = 0.03). Moreover, we identified two patients with homozygous resistance to activated protein C, which is the first description of this coagulation disorder associated with NAION. Patients without cardiovascular risk factors had a statistically significant higher frequency of coagulation disorders than patients with these risk factors (p = 0.038).
Our results indicate that thrombophilic disorders are associated with the development of non-arteriitic ischaemic optic neuropathy in patients < 60 years of age at the time of a first thromboembolic event. Selective screening of young patients and patients without cardiovascular risk factors may be helpful in identifying NAION patients with thrombophilic defects.
凝血异常对非动脉炎性缺血性视神经病变(NAION)的潜在影响,单独以及与心血管危险因素共同作用时,仍不明确。
在一项前瞻性病例对照研究中,对26例首次发生NAION或既往有血栓栓塞事件且年龄<60岁的NAION患者,以及50例年龄和性别匹配的受试者,前瞻性地筛查易栓症危险因素。
总体而言,26例患者中有12例(46.2%)存在易栓症缺陷,50例对照中有9例(18%)存在易栓症缺陷(p = 0.01)。最常见的凝血障碍是凝血因子VIII水平升高(p = 0.04)和脂蛋白(a)升高(p = 0.03)。此外,我们还发现了2例对活化蛋白C纯合抵抗的患者,这是首次描述与NAION相关的这种凝血障碍。无心血管危险因素的患者凝血障碍发生率在统计学上显著高于有这些危险因素的患者(p = 0.038)。
我们的结果表明,在首次发生血栓栓塞事件时年龄<60岁的患者中,易栓症与非动脉炎性缺血性视神经病变的发生相关。对年轻患者和无心血管危险因素的患者进行选择性筛查,可能有助于识别有易栓症缺陷的NAION患者。